Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity

por Henkels, Karen M., Rehl, Kristen M., Cho, Kwang-jin
Publicado 2021

Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling

por Garrido, Christian M., Henkels, Karen M., Rehl, Kristen M., Liang, Hong, Zhou, Yong, Gutterman, Jordan U., Cho, Kwang-jin
Publicado 2020

A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95

por Rehl, Kristen M, Selvakumar, Jayaraman, Pitsch, Rhonda L, Hoang, Don, Arumugam, Kuppuswamy, Harshman, Sean W, Gorfe, Alemayehu A, Cho, Kwang-Jin
Publicado 2023